Eiko Lifesciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2025 ,inter alia, to consider and approve 1. To consider and approve Unaudited Financial Results (Standalone & Consolidation basis) of the Company for the quarter ending on 31stDecember, 2025.